RECORDATI INDUSTRIA CHIMICA

Recordati Shares Dip Slightly as New BioGaia Probiotic Deal Unveils European Expansion

Recordati’s recent stock dip and exclusive BioGaia probiotic deal reveal market dynamics and growth prospects for the Italian pharma group.

RECORDATI INDUSTRIA CHIMICA
Italy
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

23/10/2026, 12:25

2 minutes to read

Recordati Expands in Spain & Portugal with Exclusive BioGaia Probiotic Deal

Recordati expands its Iberian footprint with a new exclusive BioGaia probiotic distribution deal, boosting portfolio diversity and positioning for long‑term growth.

RECORDATI INDUSTRIA CHIMICA
Italy
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

22/10/2026, 16:42

3 minutes to read

Recordati Shares Hold Steady at €53, Flat 24-Hour Market Move

Recordati Industria Chimica: flat 0 % price action at EUR 53, 52‑week highs at EUR 54.45, 10.9 bn market cap, no major swing in 24 hrs.

RECORDATI INDUSTRIA CHIMICA
Italy
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

21/10/2026, 09:00

2 minutes to read